Low sustained virologic response (SVR) rates in genotype (GT) 2 and 3 patients with quantifiable hepatitis C virus (HCV) at weekly 4 or treatment with Sofosbuvir (SOF) containing regimens
Document Type
Other
Publication Date
12-2016
Recommended Citation
Thornton, K., Deming, P., Sedillo, M., et al. Low sustained virologic response (SVR) rates in genotype (GT) 2 and 3 patients with quantifiable hepatitis C virus (HCV) at weekly 4 or treatment with Sofosbuvir (SOF) containing regimens. Journal of Hepatology. 2016; 64:S786. April 2016: The International Liver Congress, Abstract SAT-193. https://doi.org/10.1016/S0168-8278(16)01533-6
COinS